AU1234399A - Sustained release formulations comprising alpha-glucosidase-i nhibitors - Google Patents

Sustained release formulations comprising alpha-glucosidase-i nhibitors

Info

Publication number: AU1234399A
Authority: AU; Australia
Prior art keywords: nhibitors; glucosidase; alpha; sustained release; release formulations
Prior art date: 1997-11-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU12343/99A

Inventor

John Amatruda

Patrick Bosche

Erich Brendel

David Goldman

Carola Portner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee

Bayer AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-25

Filing date

1998-11-11

Publication date

1999-06-15

1998-11-11 Application filed by Bayer AG filed Critical Bayer AG

1999-06-15 Publication of AU1234399A publication Critical patent/AU1234399A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU12343/99A 1997-11-25 1998-11-11 Sustained release formulations comprising alpha-glucosidase-i nhibitors Abandoned AU1234399A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US6669897P	1997-11-25	1997-11-25
US60066698		1997-11-25
PCT/EP1998/007198 WO1999026606A2 (en)	1997-11-25	1998-11-11	SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS

Publications (1)

Publication Number	Publication Date
AU1234399A true AU1234399A (en)	1999-06-15

Family

ID=22071124

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU12343/99A Abandoned AU1234399A (en)	1997-11-25	1998-11-11	Sustained release formulations comprising alpha-glucosidase-i nhibitors

Country Status (5)

Country	Link
JP (1)	JP2001523704A (en)
AR (1)	AR017664A1 (en)
AU (1)	AU1234399A (en)
WO (1)	WO1999026606A2 (en)
ZA (1)	ZA9810710B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL143225A (en) *	2000-05-24	2008-03-20	Pfizer	Preparation of medicaments containing alpha-amylase inhibitors for the treatment of rumen acidosis
GB0203296D0 (en)	2002-02-12	2002-03-27	Glaxo Group Ltd	Novel composition
US8637512B2 (en)	2002-07-29	2014-01-28	Glaxo Group Limited	Formulations and method of treatment
JP4540475B2 (en)	2002-08-08	2010-09-08	キッセイ薬品工業株式会社	Pyrazole derivative, pharmaceutical composition containing the same, pharmaceutical use thereof and production intermediate thereof
ES2468219T3 (en)	2004-03-04	2014-06-16	Kissei Pharmaceutical Co., Ltd.	Nitrogen condensate ring derivatives, medicinal compositions containing derivatives and their use as drugs
CN102631332A (en) *	2012-04-28	2012-08-15	邹立兴	Voglibose tablet and preparation method thereof
CN104013590A (en) *	2014-05-09	2014-09-03	万特制药(海南)有限公司	Acarbose-containing medicinal composition and preparation method thereof
WO2016001843A1 (en) *	2014-06-30	2016-01-07	Sun Pharmaceutical Industries Limited	Extended-release gastroretentive tablets of voglibose
MY195038A (en) *	2014-12-17	2023-01-04	Empros Pharma Ab	A Modified Release Composition of Orlistat and Acarbose for the Treatment of Obesity and Related Metabolic Disorders
CN110898025A (en) *	2019-12-12	2020-03-24	湖北欣泽霏药业有限公司	Acarbose sustained-release preparation and preparation method thereof
CN111265489A (en) *	2020-03-10	2020-06-12	乐普制药科技有限公司	Divisible acarbose pellet sustained-release tablet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3134591A1 (en) *	1981-09-01	1983-03-10	Bayer Ag, 5090 Leverkusen	NEW MEDICINE PREPARATIONS FOR GLYCOSIDE HYDROLASE INHIBITORS
DK97986A (en) *	1985-03-08	1986-09-09	Takeda Chemical Industries Ltd	Means for inhibiting the digestion of saccharide
ATE86853T1 (en) *	1988-08-22	1993-04-15	Takeda Chemical Industries Ltd	ALPHA-GLUCOSIDASE INHIBITOR TO PROMOTE CALCIUM ABSORPTION.
TW272942B (en) *	1993-02-10	1996-03-21	Takeda Pharm Industry Co Ltd

1998
- 1998-11-11 WO PCT/EP1998/007198 patent/WO1999026606A2/en not_active Application Discontinuation
- 1998-11-11 JP JP2000521808A patent/JP2001523704A/en active Pending
- 1998-11-11 AU AU12343/99A patent/AU1234399A/en not_active Abandoned
- 1998-11-24 ZA ZA9810710A patent/ZA9810710B/en unknown
- 1998-11-24 AR ARP980105946A patent/AR017664A1/en unknown

Also Published As

Publication number	Publication date
WO1999026606A2 (en)	1999-06-03
WO1999026606A3 (en)	1999-08-12
AR017664A1 (en)	2001-09-12
ZA9810710B (en)	1999-06-14
JP2001523704A (en)	2001-11-27

Publication	Publication Date	Title
AU1689599A (en)	1999-07-19	Sustained release medicinal compositions
AU1617399A (en)	1999-06-28	Glp-1 formulations
GB9715751D0 (en)	1997-10-01	Formulations
AU3854295A (en)	1996-07-03	Sustained release caffeine formulation
AU1916599A (en)	1999-10-25	Sachet formulations
AU1640097A (en)	1997-10-02	Extended release formulation
AU5200098A (en)	1998-05-29	Sustained release formulation containing dfmo
AU7490098A (en)	1998-12-08	Cationic amphiphile formulations
AU6513298A (en)	1998-10-12	Therapeutic compositions
AU3560497A (en)	1998-03-06	Anthelmintic formulations
AU6593498A (en)	1998-12-03	Controlled release compositions
HRP20000213B1 (en)	2004-04-30	Extended release formulation
AU5037800A (en)	2000-12-18	Adhesive formulations
AU8053898A (en)	1998-12-30	Immunogenic compositions
AU8815998A (en)	1999-03-16	Synthetic detergent formulations
AU1234399A (en)	1999-06-15	Sustained release formulations comprising alpha-glucosidase-i nhibitors
AU3261297A (en)	1998-01-21	New insecticide formulations
AU7066098A (en)	1998-11-13	Perfumes comprising 3-alkylcycloalkanols
AU2063399A (en)	1999-07-26	Embolizing compositions comprising surfactants
AUPP279698A0 (en)	1998-04-30	Sustained release formulation
AU6220798A (en)	1998-09-22	Release agent
AU1063699A (en)	1999-04-27	Release compositions
AU6607798A (en)	1998-09-22	Immunopotentiating formulations for vaccinal use
AU6475898A (en)	1998-11-12	Solid formulations for crop protection
AU5814498A (en)	1999-06-07	Novel release latch - c-i-p

Legal Events

Date	Code	Title	Description
2000-08-10	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase